Test bank for lippincott illustrated reviews Pharmacology 7th Ed Whalen all 48 chapters complete

TESTBANK f




Lippincott Illustrated Reviews: Phar
f f f




macology 7th Edition by Karen Whale
f f f f f




n




TESTBANK f

,PharmacologyfIllustratedfReviewsf7thfEditionfWhalenfTestfBankfTABLEf

OFfCONTENT
Chapterf1:fPharmacokinetics
Chapterf2:fDrug–ReceptorfInteractionsfandfPharmacodynamics
Chapterf3:fThefAutonomicfNervousfSystem
Chapterf4:fCholinergicfAgonists
Chapterf5:fCholinergicfAntagonists
Chapterf6:fAdrenergicfAgonists
Chapterf7:fAdrenergicfAntagonists
Chapterf8:fDrugsfforfNeurodegenerativefDiseases
Chapterf9:fAnxiolyticfandfHypnoticfDrugs
Chapterf10:fAntidepressants
Chapterf11:fAntipsychoticfDrugs
Chapterf12:fDrugsfforfEpilepsy
Chapterf13:fAnesthetics
Chapterf14:fOpioids
Chapterf15:fDrugsfoffAbuse
Chapterf16:fCNSfStimulants
Chapterf17:fAntihypertensives
Chapterf18:fDiuretics
Chapterf19:fHeartfFailure
Chapterf20:fAntiarrhythmics
Chapterf21:fAntianginalfDrugs
Chapterf22:fAnticoagulantsfandfAntiplateletfAgents
Chapterf23:fDrugsfforfHyperlipidemia
Chapterf24:fPituitaryfandfThyroid
Chapterf25:fDrugsfforfDiabetes
Chapterf26:fEstrogensfandfAndrogens
Chapterf27:fAdrenalfHormones
Chapterf28:fDrugsfforfObesity
Chapterf29:fDrugsfforfDisordersfoffthefRespiratoryfSystem
Chapterf30:fAntihistamines
Chapterf31:fGastrointestinalfandfAntiemeticfDrugs
Chapterf32:fDrugsfforfUrologicfDisorders
Chapterf33:fDrugsfforfAnemia
Chapterf34:fDrugsfforfDermatologicfDisorders
Chapterf35:fDrugsfforfBonefDisorders
Chapterf36:fAnti-inflammatory,fAntipyretic,fandfAnalgesicfAgents
Chapterf37:fPrinciplesfoffAntimicrobialfTherapy
Chapterf38:fCellfWallfInhibitors
Chapterf39:fProteinfSynthesisfInhibitors
Chapterf40:fQuinolones,fFolicfAcidfAntagonists,fandfUrinaryfTractfAntiseptics
Chapterf41:fAntimycobacterialfDrugs
Chapterf42:fAntifungalfDrugs
Chapterf43:fAntiprotozoalfDrugs
Chapterf44:fAnthelminticfDrugs
Chapterf45:fAntiviralfDrugs
Chapterf46:fAnticancerfDrugs
Chapterf47:fImmunosuppressants
Chapterf48:fClinicalfToxicology

, PharmacologyfIllustratedfReviewsf7thfEditionfWhalenfT

estfBank

Chapterf1:fPharmacokineticsfMU

LTIPLEfCHOICE

1. fWhichfdrugsfwillfgofthroughfafpharmaceuticfphasefafterfitfisfadministered?
a. Intramuscularfcephalosporins
b. Intravenousfvasopressors
c. Oralfanalgesics
d. Subcutaneousfantiglycemicsf
ANS:fC
Whenfdrugsfarefadministeredfparenterally,ftherefisfnofpharmaceuticfphase,fwhichfoccursfwhenfafdrugf
becomesfafsolutionfthatfcanfcrossfthefbiologicfmembrane.

DIF:fCOGNITIVEfLEVEL:fUnderstandingf(Comprehension)fREF:fdmf3fTOP:f
NURSINGfPROCESS:fAssessment
MSC:fNCLEX:fPhysiologicalfIntegrity:fPharmacologicalfandfParenteralfTherapies

2. Thefnursefisfpreparingftofadministerfanforalfmedicationfandfwantsftofensurefafrapidfdrugfacti
on.fWhichfformfoffthefmedicationfwillfthefnursefadminister?
a. Capsule
b. Enteric-coatedfpill
c. Liquidfsuspension
d. Tablet
ANS:fC
f


Liquidfdrugsfarefalreadyfinfsolution,fwhichfisfthefformfnecessaryfforfabsorptionfinfthefGIftract.fThef
otherfformsfmustfdisintegratefintofsmallfparticlesfandfthenfdissolvefbeforefbeingfabsorbed.

DIF:fCOGNITIVEfLEVEL:fUnderstandingf(Comprehension)fREF:fdmf3fTOP:f
NURSINGfPROCESS:fNursingfIntervention
MSC:fNCLEX:fPhysiologicalfIntegrity:fPharmacologicalfandfParenteralfTherapies

, Stuvia.comf-fThefMarketplaceftofBuyfandfSellfyourfStudy




3. Thefnursefisfteachingfafpatientfwhofwillfbefdischargedfhomefwithfafprescriptionfforfanfenteric-
coatedftablet.fWhichfstatementfbyfthefpatientfindicatesfunderstandingfoffthefteaching?
a. Ifmayfcrushftheftabletfandfputfitfinfapplesauceftofimprovefabsorption.
b. Ifshouldfconsumefacidicffoodsftofenhancefabsorptionfoffthisfmedication.
c. Ifshouldfexpectfafdelayfinfonsetfoffthefdrugsfeffectsfafterftakingftheftablet.
d. Ifshouldftakefthisfmedicationfwithfhigh-
fatffoodsftofimprovefitsfaction.fANS:fC
Enteric-
coatedftabletsfresistfdisintegrationfinfthefacidicfenvironmentfoffthefstomachfandfdisintegratefwhenfth
eyfreachfthefsmallfintestine.fTherefisfusuallyfsomefdelayfinfonsetfoffactionsfafterftakingfthesefmedicat
ions.fEnteric-
coatedftabletsfshouldfnotfbefcrushedforfchewed,fwhichfwouldfalterftheftimefandflocationfoffabsorptio
n.fAcidicffoodsfwillfnotfenhancefthefabsorptionfoffthefmedication.fThefpatientfshouldfnotftofeatfhigh-
fatffoodfbeforefingestingfanfenteric-coatedftablet,fbecausefhigh-
fatffoodsfdecreasefthefabsorptionfrate.

DIF:fCOGNITIVEfLEVEL:fApplyingf(Application)fREF:fdmf3fTOP:f
NURSINGfPROCESS:fNursingfIntervention
MSC:fNCLEX:fPhysiologicalfIntegrity:fPharmacologicalfandfParenteralfTherapies

4. Afpatientfwhofisfnewlyfdiagnosedfwithftypef1fdiabetesfmellitusfasksfwhyfinsulinfmustfbefgivenfb
yfsubcutaneousfinjectionfinsteadfoffbyfmouth.fThefnursefwillfexplainfthatfthisfisfbecause
a. absorptionfisfdiminishedfbyftheffirst-passfeffectsfinfthefliver.
b. absorptionfisffasterfwhenfinsulinfisfgivenfsubcutaneously.
c. digestivefenzymesfinfthefgastrointestinalftractfpreventfabsorption.
d. theforalfformfisflessfpredictablefwithfmorefadversefeffects.fA
NS:fC
Insulin,fgrowthfhormones,fandfotherfprotein-
basedfdrugsfarefdestroyedfinfthefsmallfintestinefbyfdigestivefenzymesfandfmustfbefgivenfparenterally.f
Becausefinsulinfisfdestroyedfbyfdigestivefenzymes,fitfwouldfnotfmakefitftofthefliverfforfmetabolismfwi
thfaffirst-
passfeffect.fSubcutaneousftissuefhasffewerfbloodfvessels,fsofabsorptionfisfslowerfinfsuchftissue.fInsuli
nfisfgivenfsubcutaneouslyfbecausefitfisfdesirableftofhavefitfabsorbfslowly.

DIF:fCOGNITIVEfLEVEL:fUnderstandingf(Comprehension)fREF:fdmf3fTOP:f
NURSINGfPROCESS:fNursingfIntervention:fPatientfTeaching
MSC:fNCLEX:fPhysiologicalfIntegrity:fPharmacologicalfandfParenteralfTherapies